StockWatch
·
Medicinal Chemicals & Botanical Products
Quarterly ResultAug 6, 2026, 06:17 AM

Curaleaf Q2 Net Income $12.5M; Revenue $340.1M, up 9.5%

AI Summary

Curaleaf Holdings, Inc. reported a significant financial turnaround for the second quarter ended June 30, 2026, achieving a net income of $12.5 million, a substantial improvement from a net loss of $53.2 million in the same period last year. The company's total revenues increased by 9.5% to $340.1 million. Additionally, Curaleaf completed a 1-for-3 reverse stock split in June 2026 and exchanged $142.2 million in Senior Secured Notes due 2026 for new notes due 2029.

Key Highlights

  • Net income attributable to Curaleaf Holdings, Inc. was $12.5 million for Q2 2026, up from a $53.2 million loss in Q2 2025.
  • Total revenues, net, increased to $340.1 million for Q2 2026, a 9.5% rise from $310.6 million in Q2 2025.
  • Basic net income per share was $0.05 for Q2 2026, compared to a loss of $0.26 per share in Q2 2025.
  • The company effected a 1-for-3 reverse stock split on June 5, 2026.
  • Senior Secured Notes of $142.2 million were exchanged for Senior Secured Notes – 2029 on a non-cash basis.
  • As of June 30, 2026, Curaleaf operated 173 dispensaries in the U.S.
  • Cash and cash equivalents stood at $94.6 million as of June 30, 2026.
  • Total assets were $2.81 billion as of June 30, 2026.